File SF4978 ("Allows conflicted formulary committee members to participate") is before the Minnesota Legislature and has not been decided. Latest step (April 7, 2026): Introduction and first reading.
Minnesota file SF4978, before the Minnesota Legislature. Still to be decided as of 2026-04-07.
Your prescription drug coverage decisions shaped by interested parties Formulary committee members who profit from or work for drug manufacturers can now participate in discussions and votes that determine which medications insurance plans cover and at what cost.
Potential upward pressure on drug prices and coverage costs When committee members with financial stakes in pharmaceutical companies influence formulary decisions, studies suggest formularies tend to favor more expensive drugs, which can increase premiums and out-of-pocket costs across entire insurance pools.
Removes safeguards designed to prevent conflicts of interest The bill eliminates or relaxes prior restrictions that kept conflicted members out of formulary decisions; critics warn this reverses conflict-of-interest protections and lacks transparency requirements or voting recusal rules to mitigate bias.
Formulary Committee members with a potential conflict of interest permission to participate in committee communications and discussions
Read the official record for SF4978
See everything up for a vote · This week in Minnesota · See what we have filed with the clerk